Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

3.325 +0.195 (+6.23%)
Streaming Delayed Price Updated: 2:18 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
From Quanterix Corporation
Via Business Wire
News headline image
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Announces Date of 2026 Annual Meeting
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
From Quanterix Corporation
Via Business Wire
News headline image
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
From Quanterix
Via Business Wire
News headline image
Quanterix to Participate in Upcoming Investor Conferences
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
From Quanterix
Via Business Wire
News headline image
Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer’s Risk Profiling
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Financial Results for the Third Quarter of 2025
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025
From Quanterix
Via Business Wire
News headline image
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Financial Results for the Second Quarter of 2025
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Announces Cooperation Agreement with Kent Lake Capital
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Expands Reach with IVD and Large Reference Labs
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix to Present at Goldman Sachs Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix Releases Financial Results for the First Quarter of 2025
From Quanterix Corporation
Via Business Wire
News headline image
Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025
From Quanterix Corporation
Via Business Wire
News headline image
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
From Kent Lake PR LLC
Via Business Wire
News headline image
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.